NLS Pharmaceutics regains full compliance with Nasdaq listing rules
The Fly

NLS Pharmaceutics regains full compliance with Nasdaq listing rules

NLS Pharmaceutics (NLSP) has received notice from the Nasdaq Stock Market informing the Company that it has regained full compliance with the bid price requirement in Listing Rule 5550(a)(2) and the equity requirement in Listing Rule 5550(b)(1).

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App